Don't miss out on Tuesday 29th October 2024, when Sage Therapeutics (NASDAQ: SAGE) will disclose its third quarter financial results after market close. Investors will have the chance to learn more about the company's performance during the quarter.
Wall Street financial experts forecast that the organization is set to announce an expected $1.53 loss per share for the quarter. Moreover, the company is anticipated to disclose a total revenue of $10.8 million for this particular period.
Analysts on Wall Street have shared their predictions regarding the annual performance of the company, estimating a total revenue of $39.98 million. Additionally, they are expecting the company to achieve per share loss of $6.51 for the fiscal year.
In the same three months of the year before, the company made loss of $3.37 per share, as shown in their financial report. This number came from the total revenue of $2.72 million that the company earned in that particular quarter.
Additionally, The company will host a conference call with investors and analysts on 29th October 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
During Friday's trading, Sage Therapeutics (SAGE) shares reached a low of $7.84 and a high of $8.16, along with a total volume of 661.80 thousand shares. The stock ended the regular trading session at $8.01, showing a gain of 2.04 percent.
